Despite the benefits of adding marine lipids rich in n-3 polyunsaturated fatty acids (PUFA) to ruminant diets to improve milk fatty acid (FA) composition, this strategy induces milk fat depression (MFD), precluding its application under practical conditions. The MFD elicited by marine lipids has tentatively been explained by a shortage of available ruminal 18:0 for mammary uptake and Δ 9 -desaturation to cis-9 18:1, which might increase milk fat melting point and impair fat secretion. This hypothesis was challenged in a recent experiment in dairy ewes, as diet supplementation with 2% DM of 18:0 did not prove useful to alleviate fish oil-induced MFD. However, further research with higher levels of 18:0 inclusion seemed advisable. Therefore, in this study, 16 lactating ewes were allocated to 4 treatments lasting 27 days: a total mixed ration containing no additional lipid (control) or 2% DM of fish oil alone (FO) diets (e.g., cis-9 16:1, cis-11 18:1, trans-10 18:1, 10-oxo-18:0, or trans-10 cis-15 18:2) might account for the absence of a positive effect of dietary 18:0. The estimated milk fat melting point was lower in the three supplemented diets (on average, -2.6ºC compared with the control). In conclusion, addition of high doses of stearic acid to the diet (at 3 and 4% DM) was not able to alleviate the MFD caused by the concomitant supplementation with fish oil. This lack of response would further challenge the hypothesis suggesting that fish oil-induced MFD is mainly explained by decreased ruminal production of 18:0 and subsequent problems of milk fat fluidity, but further research would be still needed.
Introduction
Supplementation of dairy ewe diets with marine lipids rich in n-3 polyunsaturated fatty acids (PUFA) is known to be able to modulate milk fatty acid (FA) composition towards a potentially healthier profile for consumers [e.g., with a higher proportion of trans-11 18:1, cis-9 trans-11 conjugated linoleic acid (CLA) and very long-chain n-3 PUFA; Reynolds et al., 2006; Toral et al., 2010; Tsiplakou and Zervas, 2013] . The low levels that are required (usually, ≤ 2% diet DM) would have no negative effects on shelflife and sensory properties of dairy products (e.g., Jones et al., 2005) .
However, besides beneficial effects, this feeding strategy causes milk fat depression (MFD; Rego et al., 2005; Bichi et al., 2013; Carreño et al., 2016) , which precludes its use under practical conditions, particularly in sheep and goat farms where most milk is used for the manufacture of cheeses (Chilliard et al., 2006; Ramos and Juárez, 2011) .
Several hypotheses or theories explaining the origin of MFD have been proposed and subsequently found inadequate or incomplete (Bauman and Griinari, 2001; Shingfield and Griinari, 2007) . The Biohydrogenation (BH) theory proposed by Bauman and Griinari in 2001 establishes that MFD relates to an inhibition of mammary lipogenesis by specific BH intermediates that are produced under certain feeding conditions that alter rumen function. This is the most widely accepted theory. Another hypothesis, trying to explain more specifically the marine lipid-induced MFD, is based on the shortage of 18:0 (caused by the inhibitory action of marine lipids on the last step of rumen BH; Loor et al., 2005; Shingfield and Griinari, 2007) for cis-9 18:1 synthesis in the mammary gland. Since this latter FA has a low melting point, its scarcity would exert a negative impact on the maintenance of milk fat melting point (MMP) below body temperature (Timmen and Patton, 1988; Bernard et al., 2013) and, consequently, on milk fat fluidity and secretion, causing the low-fat milk syndrome (Chilliard et al., 2007; Shingfield and Griinari, 2007) .
Nevertheless, in a previous dedicated study with lactating ewes (Toral et al., 2016) , we observed the same reduction in milk fat concentration and yield (20%) in sheep supplemented with fish oil (2% DM) alone or in combination with stearic acid (SA, 2% DM). The lack of effect of dietary SA challenged the premise of a shortage of this FA to explain fish oil-induced MFD in dairy ewes. However, before ruling out a mechanism based on decreased ruminal production of 18:0 and subsequent alterations of milk fat fluidity, we decided to conduct a new assay with higher doses of SA (i.e., 3 and 4% DM).
Material and methods

All experimental procedures were approved and completed in accordance with
Spanish and EU legislations (R.D. 53/2013, and Council Directive 2010/63/EU) for the protection of animals used for experimental purposes.
Animals, experimental diets and management
Sixteen lactating Assaf ewes (79.0 ± 2.94 kg of body weight; 83.4 ± 2.65 days in milk at the beginning of the assay) were housed in tie stalls and allocated to one of 4 groups (n = 4). Dietary treatments were comprised of alfalfa hay and a concentrate (40:60) and contained no additional lipid (control) or 2% DM of fish oil (Afampes 121 DHA; Afamsa, Mos, Spain) alone (FO) or in combination with 3% (FOSA3) or 4% (FOSA4) DM of SA (prilled free FA supplement; Edenor C18 98-100; Oleo Solutions, York, UK).
The ingredients and chemical composition of the experimental diets, which were prepared weekly, are shown in Table 1 . To try to reduce selection of components, diets included molasses and were offered as total mixed rations (TMR). All sheep were fed the control TMR during 3 weeks of adaptation before the start of the study, and then the 4 experimental treatments for 27 more days. The diets were offered ad libitum twice daily, at 09:30 and 18:30 h, and clean drinking water was always available. Ewes were milked at approx. 09:00 and 18:00 h in a 1 × 10 stall-milking parlor (DeLaval, Madrid, Spain).
Measurements and sampling procedures
Representative samples of the experimental diets, collected weekly, and the fish oil and stearic acid were stored at -30ºC until analysis. Feed intake was recorded each week by weighing the amount of DM offered and refused by each lot of 4 sheep.
Milk yield was recorded on days 25, 26 and 27 on the experimental diets. Individual milk samples were collected and composited according to morning and evening milk yield. One 10-mL aliquot of composite milk was stored at -30ºC until milk FA composition analysis; another aliquot of 50 mL was preserved with bronopol (D & F Control Systems Inc., San Ramon, CA, USA) and stored at 4ºC until analyzed for fat, protein, lactose and total solids.
Chemical analysis
Diets
Samples were analyzed for DM (ISO 6496:1999) , ash (ISO 5984:2002) , and crude protein (ISO 5983-2:2009 ). The neutral and acid detergent fibres (aNDF and ADF) were determined using an Ankom 2000 fiber analyzer (Ankom Technology Methods 13 and 12, respectively; Ankom Technology Corp., Macedon, NY, USA); the former was assayed with sodium sulfite and α-amylase, and both were expressed with residual ash. Fatty acid methyl esters of lipid in freeze-dried samples of TMR were prepared in a 1-step extraction-transesterification procedure using chloroform and 2% (vol/vol) sulfuric acid in methanol (Shingfield et al., 2003) , and cis-12 tridecenoate (Larodan, Solna, Sweden) as an internal standard. Methyl esters were separated and quantified using a gas chromatograph (Agilent 7890A GC System, Agilent Technologies Inc., Santa Clara, CA, USA) equipped with a flame-ionization detector and a 100-m fused silica capillary column (0.25 mm i.d., 0.2-μm film thickness; CP-SIL 88, CP7489, Varian Ibérica S.A., Madrid, Spain) and hydrogen as the carrier gas (207 kPa, 2.1 mL/min). The total FAME profile in a 2-μL sample volume at a split ratio of 1:50 was determined using a temperature gradient program (Shingfield et al., 2003) . Peaks were identified based on retention time comparisons with commercially available standard FAME mixtures (NuChek Prep., Elysian, MN, USA; and Sigma-Aldrich, Madrid, Spain).
Milk
Fat, protein, lactose and total solid concentrations were determined by infrared spectrophotometry (ISO 9622:1999) using a MilkoScan FT6000 (Foss, Hillerød, Denmark). Lipid in 1 mL of milk was extracted using diethylether and hexane (5:4, vol/vol) and transesterified to fatty acid methyl ester (FAME) using freshly prepared methanolic sodium methoxide as a catalyst (Shingfield et al., 2003) . The total FAME profile was determined by gas chromatography using the same chromatograph and temperature gradient program applied for the analysis of feeds, but isomers of 18:1 were further resolved in a separate analysis under isothermal conditions at 170ºC (Shingfield et al., 2003) . Peaks were identified based on retention time comparisons with the same FAME mixtures used for the analysis of feeds, other commercially available standards (Nu-Chek Prep.; Sigma-Aldrich; and Larodan), cross referencing with chromatograms reported in the literature (Shingfield et al., 2003; Halmemies-Beauchet-Filleau et al., 2011) , and comparison with reference samples for which the FA composition was determined based on gas chromatography analysis of FAME and GC-MS analysis of corresponding 4,4-dimethyloxazoline derivatives (Bichi et al., 2013) .
Calculations and statistical analysis
The mean MMP was estimated as the sum of the melting points of individual FA (95 in total) weighted by their respective molar proportions (Toral et al., 2013) .
All statistical analyses were performed using the SAS software package (version 9.4; SAS Institute Inc., Cary, NC, USA Differences were declared significant at P < 0.05 and considered a trend towards significance at P < 0.10. Least squares means are reported.
Results
Animal performance
Data of animal performance are shown in Table 2 . According to the experimental design, addition of fish oil to the diet caused MFD, which was characterized by a significant lower milk fat concentration in ewes consuming this supplement (i.e., FO, FOSA3 and FOSA4) compared to those on the control (P < 0.01). Fat production (g/day)
was not significantly reduced due to the numerically (although not statistically significant; P > 0.10) higher milk production in these supplemented animals. Within them (i.e., in ewes fed the FO, FOSA3 and FOSA4 diets) similar milk yields were observed (P > 0.10). The lower fat concentrations were reflected in lower contents of total solids in ewes on the three treatments containing fish oil (P < 0.05), without significant variations between or between FOSA3 and FOSA4 (P > 0.10) . No variations were detected in protein or lactose either (P > 0.10).
Values of DMI were similar for the 4 treatments and remained relatively stable throughout the trial (on average, 3.33 ± 0.06, 3.28 ± 0.11, 3.07 ± 0.16 and 3.31 ± 0.05 kg DM/day for control, FO, FOSA3 and FOSA4). They were not statistically analysed and included in Table 2 because they were recorded for the lot and not individually.
Milk fatty acid composition
As shown in Table 3 , all diets supplemented with fish oil modified the proportion of several individual short and medium-chain FA but, as a whole, only the addition of SA (FOSA3 and FOSA4) reduced the concentration of <C16 and C16 FA (P < 0.05). On the contrary, FOSA-diets increased the proportion of >C16 FA: the higher the dose of SA, the greater the concentration of >C16 FA (P < 0.05).
The sum of saturated FA was decreased by FO-diets (P < 0.001), the strongest effects being observed with FOSA3 and FOSA4 (P < 0.001) but without significant differences between them (P > 0.10 for FOSA3 vs. FOSA4). This reduction was largely due to the lower concentration of 18:0 in the milk from sheep on the diet supplemented with fish oil alone (FO; 1.36%) compared with the control (7.18%), as well as in FOSA3
(4.23%) and FOSA4 (5.42%), with significant differences between the two latter (P < 0.05). Decreases in 10:0, 12:0 and 16:0 concentrations after SA addition would contribute to explain the differences in total saturates between FO and FOSA treatments (P < 0.05).
Some significant increases in individual saturated FA in response to fish oil were also observed (e.g., in 6:0, 8:0 and 10-oxo-18:0).
In general, the addition of SA, regardless of the dose, caused little changes in odd-and branched-chain FA and in 16:1 isomers that had already being altered by FO (e.g., cis-9 16:1; P < 0.001).
Concentrations of most trans-18:1 isomers were increased by all FO-diets (P < 0.05), with differences between FO and FOSA3+FOSA4 in some cases. For instance, this was particularly clear for trans-10 18:1 (P < 0.10), which showed values reaching up to 13-fold increases when animals received dietary SA, and for trans-11 18:1 (P < 0.05).
Isomers of cis-18:1 were also significantly affected by consumption of fish oil or SA. As expected, most remarkable changes occurred in cis-9 18:1, with a strong reduction when fish oil alone was provided (5.91 in FO vs. 12.53% in control) that was partially reverted in FOSA3 (9.50%) and FOSA4 (11.28%). Differences were detected not only between FO-and FOSA-diets (P < 0.001) but also between the two latter (i.e., FOSA3
and FOSA4). Decreases in milk cis-9 18:1 and 18:0 were not equivalent, which resulted in an increment in the Δ 9 -desaturation index based on the cis-9 18:1/(cis-9 18:1 + 18:0) ratio that was particularly high in FO (0.813 ± 0.0050), compared with the control (0.636 ± 0.0467) and FOSA diets (on average, 0.684 ± 0.0071).
The positive effect of fish oil supplementation on the concentration of total CLA was limited by the addition of SA to the diet. This was evident, for example, in the cis-9 trans-11 CLA isomer, which was strongly increased by FO alone and to a lower extent by FOSA3 and FOSA4 (P < 0.05). On the other hand, the proportion of trans-10 cis-12 CLA was only favoured by dietary SA (P < 0.05). Diet-induced variations in other 18-carbon PUFA (e.g., 18:2n-6 or 18:3n-3) were in general less pronounced and attributed to the action of fish oil.
Something similar occurred with C20 and C22 FA. Changes observed in these FA, particularly the enhancement of very long chain PUFA (e.g., eicosapentaenoic acid, 20:5n-3; docosapentaenoic acid, 22:5n-3; and docosahexaenoic acid, 22:6n-3), were mostly due to fish oil supplementation (P < 0.001). Only milk concentrations of 20:0 and 22:6n-3 showed higher values with the addition of SA (P < 0.01 and 0.10, respectively).
Concerning the estimated melting point, milk fat from control ewes showed higher values than that from animals fed fish oil-containing diets (i.e., FO, FOSA3 and FOSA4; P < 0.001), but without significant differences among the latter.
Discussion
Supplementation with fish oil (i.e., FO, FOSA3 and FOSA4 diets) modulated milk FA composition towards a profile potentially healthier for the consumer (Palmquist et al., 2005; Chilliard et al., 2007) . Since a number of experiments, including some conducted by our team (e.g., Toral et al., 2010; Bichi et al., 2013) , have examined this effect of marine lipids in dairy ewes (Reynolds et al., 2006; Capper et al., 2007; Tsiplakou and Zervas, 2013) and this is not the objective of the present study, this part will only be mentioned briefly. Thus, dietary addition of fish oil increased, for instance, the concentration of cis-9 trans-11 CLA, its precursor trans-11 18:1, very long chain n-3 FA (e.g., 20:5n-3, 22:5n-3 and 22:6n-3) or total PUFA. These changes agree with previous reports under similar conditions (e.g., Tsiplakou and Zervas, 2013; Toral et al., 2015) .
At the same time, as designed and expected (Capper et al., 2007; Carreño et al., 2016; Toral et al., 2016) , diet supplementation with fish oil (namely, the FO treatment) caused MFD, which was characterized by a significant lower milk fat concentration compared to that of the control. The lack of impact on milk fat production might be partly attributed to the numerical but not significant increase in milk yield. Given the high individual variation observed in this experiment for that parameter (milk yield), statistical power limitations related to the low number of animals cannot be ruled out. Nevertheless, in a previous assay in which milk yield was greater in ewes consuming fish oil (Suárez-the lower milk fat percentage was not just a dilution effect but a response to the downregulation of genes involved in mammary lipogenesis.
Decreases in milk fat concentrations were similar in ewes fed the FO, FOSA3 and under similar MFD conditions. In this respect, between 48 and 57% of milk cis-9 18:1 has been estimated to derive from 18:0 Δ 9 -desaturation in the mammary gland of dairy ewes fed a similar basal diet to that used in the present trial (Frutos et al., 2014; Toral et al., 2017) . In dairy cows consuming conserved forages and concentrates, estimations of endogenous milk cis-9 18:1 synthesis also range from approx. 48 to 64% (Griinari et al., 2000; Leskinen et al., 2016) . This FA has a low melting point (16.0ºC) and it is therefore considered to play a key role in maintaining milk fat melting point below body temperature and ensuring milk fat fluidity and secretion (Timmen and Patton, 1988; Shingfield and Griinari, 2007; Bernard et al., 2013) . In this assay, the deep decrease in 18:0 due to FO (-81%) was completely reverted neither by FOSA3 (-41%) nor by FOSA4
(-25%). Conversely, the concentration of cis-9 18:1 fell less severely with FO (-53%) and values in FOSA3 and FOSA4 (9.50 and 11.28 g/100 g FA, respectively) were closer to that of the control (12.53%). These changes are in line with those reported previously in Toral et al. (2016) and would also support that the lack of response to dietary SA supplementation, in terms of MFD severity, was not related to its dose (2, 3 or 4% DM).
In any event, decreases in 18:0 and cis-9 18:1 do not seem to be actually responsible for impaired milk fat fluidity due to inadequate melting point. In fact, estimated MMP was lower in animals receiving the three FO supplemented diets, which seems to contradict the milk fat fluidity hypothesis and some previous findings in ruminants fed marine lipids (Gama et al., 2008; Toral et al., 2010) , although it agrees with some others (Toral et al., 2013 (Toral et al., , 2016 Kairenius et al., 2015) . These inconsistences might be, at least in part, accounted for by counteracting effects on a number of individual FA, including some that would be relevant to affect MMP in one direction or another. For example, increases in some short-chain FA, some CLA isomers or 20:5n-3, 22:5n-3 and 22:6n-3, with very low melting points, and decreases in some others, such as 12:0 or 16:0, with high melting points (LipidBank Database, http://www.lipidbank.jp).
Nevertheless, mechanisms linked to milk fat fluidity cannot be completely ruled out because this study, as well as most others, was conducted on milk fat that was successfully secreted, but triacylglycerols with high melting point might accumulate in mammary epithelial cells and inhibit lipogenesis (Gama et al., 2008; Toral et al., 2016 ). Further research would be then needed before being able to firmly demonstrate or reject the hypothesis of milk fat fluidity.
Diet supplements enriched with individual FA (particularly, palmitic acid and stearic acid) are becoming progressively more available and used to enhance milk and milk fat yield (Loften et al., 2014; Boerman et al., 2017) . However, the main aim of using SA in this study was not to improve dairy sheep performance directly but indirectly through mitigation of fish oil detrimental effects.
The reasons underlying the lack of response to dietary SA in the present and in our previous trial (Toral et al., 2016) are still uncertain but may be related to dose-dependent side effects of feeding this saturated FA. A recent work by Boerman et al. (2017) has proved that although 18:0 is the main end product of BH, it is not so inert as often considered. Thus, they found that increasing doses of dietary SA caused a marked decrease in 18-carbon FA digestibility (up to approx. -30% with 2.30% of a free FA product containing 93% 18:0, very similar to our supplement). Alterations of rumen lipid metabolism, which are suggested, for example, by large increments in milk trans-10 18:1, in trans-6+7, trans-8 and trans-9 16:1, or in 10-oxo-18:0, and poor mammary uptake might also be behind the absence of effects (Enjalbert et al., 1998; Toral et al., 2016) .
As previously suspected (Leskinen et al., 2016; Toral et al., 2016) , results would point again to the BH theory, with a significant contribution of some FA produced under altered ruminal conditions (Bauman and Griinari, 2001; Shingfield and Griinari, 2007) .
Thus, some potentially antilipogenic FA, such as trans-10 18:1, trans-9 cis-11 and trans-10 cis-12 CLA, were favoured in the 3 diets inducing MFD. Interestingly, increases were stronger (e.g., in trans-10 18:1) or even only significant (e.g., in trans-10 cis-12 CLA) in FOSA3 and FOSA4 treatments, which may contribute to explain why the addition of 18:0 to the TMR was not able to mitigate the low-fat milk syndrome. The basal diet composition (with a high concentrate level) may also affect the extent of these rumen BH responses to lipid supplements (Chilliard et al., 2007; Shingfield and Griinari, 2007) .
Quite recently, some studies (e.g., Alves and Bessa, 2014; Kairenius et al., 2015; Toral et al., 2015) have suggested the contribution to MFD of less well-known antilipogenic FA. The inhibitory action of most of these candidate FA is only tentative yet (Kadegowda et al., 2009; Burns et al., 2012) and should be proven in further studies.
Examples of such bioactive compounds are FA promoted under altered rumen function, such as intermediates of minor 18:3n-3 biohydrogenation pathways (e.g., trans-10 cis-15
18:2, which in our chromatographic conditions coeluted with trans-11 cis-15 18:2). Other putative milk fat inhibitors include certain FA supplied with fish oil (e.g., cis-9 16:1, cis-11 18:1 and very long-chain n-3 PUFA) that might account for the reductions in milk fat synthesis after post-ruminal infusions of this marine lipid (Loor et al., 2005; Dallaire et al., 2014) . As shown in Table 3 , all these FA were similarly increased with FO and FOSA treatments, which would contribute as well to explain the lack of effect of dietary SA. were also similar in FO-and FOSA-treatments.
In conclusion, addition of high doses of stearic acid to the diet of lactating ewes (3 and 4% DM) was not able to alleviate the milk fat depression caused by the concomitant supplementation with fish oil (2% DM). In fact, the higher the dose of SA, the worse the results. This lack of response would further challenge the hypothesis suggesting that fish oil-induced MFD is mainly explained by decreased ruminal production of 18:0 and subsequent problems of milk fat fluidity, but further research would be still needed. A SED = standard error of the difference for treatment effects.
Conflicts
B Probability of the contrast. FO diets = diets containing fish oil (i.e., FO, FOSA3 and FOSA4); FOSA diets = diets containing both fish oil and 18:0 (i.e., FOSA3 and FOSA4).
C Contains trans-7 cis-9 and trans-8 cis-10 conjugated linoleic acids (CLA) as minor components.
